Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
ExoPolymer is a biotechnology company specializing in the development of high-performance, bio-inspired polymers through advanced microbial fermentation. The company's platform enables the creation of bespoke biopolymers that mimic the properties of the natural extracellular matrix, offering superior biocompatibility and functionality compared to traditional synthetic or animal-derived materials. ExoPolymer targets applications across healthcare, personal care, and industrial sectors, with a focus on advanced wound care, drug delivery systems, and sustainable high-performance ingredients. By leveraging synthetic biology, the company aims to replace petroleum-based and animal-sourced polymers with sustainable, high-purity alternatives.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on ExoPolymer.